(Q40815770)

24 September 2017

title

Effect of Clofibrate and Calcium in Type II A Hyperlipoproteinaemia (English)

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1977.TB16808.X

24 March 2023

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1977.TB16808.X

24 March 2023

author name string

A. Lehtonen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A333869

24 March 2023

J. Viikari

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A333869

24 March 2023

language of work or name

1 reference

1 January 1977

1 reference

full work available at URL

24 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.0954-6820.1977.tb16808.x

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1977.TB16808.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.0954-6820.1977.tb16808.x/fullpdf

24 March 2023

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1977.TB16808.X

24 March 2023

published in

Acta medica Scandinavica

1 reference

24 September 2017

volume

202

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

179-181

1 reference

The determination of free and esterified cholesterol in blood after separation by thin-layer chromatography

24 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1977.TB16808.X

Serum-high-density-lipoprotein and atherosclerotic heart-disease

24 March 2023

3

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1977.TB16808.X

SELECTIVE BLOOD LIPID REDUCTIONS BY NEWER PHARMACOLOGIC AGENTS

24 March 2023

4

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1977.TB16808.X

DETERMINATION OF SERUM TRIGLYCERIDES

24 March 2023

5

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1977.TB16808.X

Effects of oral calcium upon serum cholesterol and triglycerides in patients with hyperlipidemia

24 March 2023

6

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1977.TB16808.X

Lipoprotein lipid alterations with cholestyramine administration

24 March 2023

9

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1977.TB16808.X

The Treatment of Hyperlipidemia

24 March 2023

10

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1977.TB16808.X

The Current Status of Hypolipidemic Drugs

24 March 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1977.TB16808.X

Cholestyramine in type II hyperlipoproteinemia. A double-blind trial

24 March 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1977.TB16808.X

A Comparative Study of the Effects of Cholestyramine and Neomycin in the Treatment of Type II Hyperlipoproteinaemia

24 March 2023

14

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1977.TB16808.X

Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states

24 March 2023

15

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1977.TB16808.X

Fractionation of plasma lipoproteins by density gradient centrifugation in swing-out rotors

24 March 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1977.TB16808.X

EFFECTS OF ORAL CALCIUM UPON SERUM LIPIDS IN MAN

24 March 2023

18

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1977.TB16808.X

24 March 2023

Identifiers

0 references

1 reference